Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities:    
Consolidated net income $ 433.9 $ 417.2
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 506.9 461.0
Stock-based compensation expense 71.9 61.3
Deferred income taxes (45.2) (67.9)
Gain on fair market value adjustment and gain on sale of equity investments 0.0 (13.8)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (47.8) (86.4)
Other assets, current and long-term (13.3) (16.0)
Current and long term liabilities, excluding debt 93.3 39.3
Cash provided by operating activities 999.7 794.7
Investing activities:    
Capital expenditures (392.6) (455.6)
Acquisitions, net of cash acquired 0.0 (276.0)
Cash received from divestitures 0.0 6.9
Cash used in investing activities (392.6) (724.7)
Financing activities:    
Net short-term payments (195.9) (83.6)
Payments on long-term debt (695.6) (575.0)
Proceeds from issuance of long-term debt 649.8 872.9
Dividends paid to Equifax shareholders (144.8) (143.7)
Distributions paid to noncontrolling interests (4.4) (2.8)
Proceeds from exercise of stock options and employee stock purchase plan 67.5 18.6
Payment of taxes related to settlement of equity awards (16.4) (16.9)
Debt issuance costs (5.2) (6.0)
Cash (used in) provided by financing activities (345.0) 63.5
Effect of foreign currency exchange rates on cash and cash equivalents (10.7) (6.1)
Increase in cash and cash equivalents 251.4 127.4
Cash and cash equivalents, beginning of period 216.8 285.2
Cash and cash equivalents, end of period $ 468.2 $ 412.6